Inventor
CHOI WOO-BAEG
US33 patents
⚠️ This page may combine multiple inventors who share the name “CHOI WOO-BAEG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV EMORY
20 patentsUS5914331AJun 22, 1999
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
UNIV EMORY113 citations99
US5814639ASep 29, 1998
Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
UNIV EMORY139 citations99
US5539116AJul 23, 1996
Method and compositions for the synthesis of BCH-189 and related compounds
UNIV EMORY137 citations99
US5210085AMay 11, 1993
Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
UNIV EMORY178 citations99
US5204466AApr 20, 1993
Method and compositions for the synthesis of bch-189 and related compounds
UNIV EMORY134 citations99
US6703396B1Mar 9, 2004
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
UNIV EMORY64 citations96
US6642245B1Nov 4, 2003
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
UNIV EMORY65 citations96
US5914400AJun 22, 1999
Method and compositions for the synthesis of BCH-189 and related compounds
UNIV EMORY29 citations96
US5892025AApr 6, 1999
Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY45 citations96
US5827727AOct 27, 1998
Method of resolution of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY44 citations96
US5728575AMar 17, 1998
Method of resolution of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY48 citations96
US6346627B1Feb 12, 2002
Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY14 citations93
US6114343ASep 5, 2000
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane
UNIV EMORY17 citations93
US6069252AMay 30, 2000
Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY22 citations93
US5852027ADec 22, 1998
Antiviral 1,3-dioxolane nucleoside analogues
UNIV EMORY21 citations93
US5700937ADec 23, 1997
Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
UNIV EMORY43 citations93
US7402588B2Jul 22, 2008
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
UNIV EMORY5 citations74
US7160999B2Jan 9, 2007
Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY6 citations74
US6153751ANov 28, 2000
Method and compositions for the synthesis of BCH-189 and related compounds
UNIV EMORY7 citations74
US7468436B2Dec 23, 2008
Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
UNIV EMORY0 citations52
MERCK & CO INC
5 patentsUS6143885ANov 7, 2000
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC18 citations84
US5654424AAug 5, 1997
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC2 citations63
US5808082ASep 15, 1998
Method of preparing phosphodiesterase IV inhibitors
MERCK & CO INC2 citations59
US6242596B1Jun 5, 2001
Preparation of betamethyl carbapenem intermediates
MERCK & CO INC1 citations52
US5900368AMay 4, 1999
Process for bioreduction of bisaryl ketone to bisaryl alcohol
MERCK & CO INC1 citations48
FOB SYNTHESIS INC
5 patentsUS7683049B2Mar 23, 2010
Carbapenem antibacterials with gram-negative activity and processes for their preparation
FOB SYNTHESIS INC5 citations69
US10933051B2Mar 2, 2021
Carbapenem compounds and compositions for the treatment of bacterial infections
FOB SYNTHESIS INC1 citations53
US7632828B2Dec 15, 2009
Gram-positive carbapenem antibacterials and processes for their preparation
FOB SYNTHESIS INC1 citations51
US9937151B2Apr 10, 2018
Carbapenem antibacterials with gram-negative activity
FOB SYNTHESIS INC0 citations45
US9149461B2Oct 6, 2015
Carbapenem antibacterials with gram-negative activity
FOB SYNTHESIS INC1 citations45